VHL and nonpapillary renal cell carcinoma: VHL is the substrate recognition component of the multi-subunit E3 ligase complex comprising Elongin B, Elongin C, Cullin-2, Rbx1, and VHL [90], and is the tumor suppressor of clear cell renal cell carcinoma (ccRCC) [91,92].